<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Ihr Online Portal für Mitglieder und Interessierte</title>
	<atom:link href="https://alpha1-deutschland.org/en/feed" rel="self" type="application/rss+xml" />
	<link>https://alpha1-deutschland.org/en/</link>
	<description></description>
	<lastBuildDate>Mon, 16 Nov 2026 10:43:19 +0000</lastBuildDate>
	<language>en-GB</language>
	<sy:updateperiod>
	hourly	</sy:updateperiod>
	<sy:updatefrequency>
	1	</sy:updatefrequency>
	<generator>https://wordpress.org/?v=7.1.4</generator>

<image>
	<url>https://alpha1-deutschland.org/wp-content/uploads/cropped-favicon-256x256-1-32x32.png</url>
	<title>Ihr Online Portal für Mitglieder und Interessierte</title>
	<link>https://alpha1-deutschland.org/en/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Stromkosten für den Sauerstoffkonzentrator</title>
		<link>https://alpha1-deutschland.org/en/stromkosten-fuer-den-sauerstoffkonzentrator</link>
		
		<dc:creator><![CDATA[A1D-WebRedaktion]]></dc:creator>
		<pubDate>Mon, 16 Nov 2026 10:41:43 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<category><![CDATA[Hilfsmittel]]></category>
		<category><![CDATA[Sauerstoff]]></category>
		<guid ispermalink="false">https://alpha1-deutschland.org/?p=7454</guid>

					<description><![CDATA[<p>Electricity costs for the oxygen concentrator – who covers the costs? Those who are permanently dependent on oxygen therapy and use an electrically operated oxygen concentrator at home often have significantly higher electricity consumption.</p>
<p>The post <a href="https://alpha1-deutschland.org/en/stromkosten-fuer-den-sauerstoffkonzentrator">Stromkosten für den Sauerstoffkonzentrator</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></description>
										<content:encoded><![CDATA[<h1 style="font-weight: 400;"><strong>Electricity costs for the oxygen concentrator – who covers the costs?</strong></h1>
<p style="font-weight: 400;">Those who are permanently dependent on oxygen therapy and use an electrically operated oxygen concentrator at home often have significantly higher electricity consumption. What many affected individuals don't know: Statutory health insurance companies should cover the resulting additional electricity costs (based on the [relevant legal provision]). <a href="https://www.gesetze-im-internet.de/sgb_5/__33.html?level=1&amp;utm_source=chatgpt.com">Section 33 SGB V</a> and a landmark ruling by the Federal Social Court). It is therefore worthwhile to inquire with your health insurance provider and apply for reimbursement. Many health insurance providers do not automatically inform their members about reimbursement options – you must take the initiative yourself.</p>
<p style="font-weight: 400;">An oxygen concentrator is a medical device that is often used for many hours a day or even around the clock during long-term oxygen therapy. This results in additional electricity costs that can add up over the course of a year.</p>
<p style="font-weight: 400;">The provision of an assistive device generally includes not only the provision of the device itself, but also the necessary costs for its operation. Under certain conditions, this also includes electricity costs. <a href="https://www.verbraucherzentrale.de/wissen/gesundheit-pflege/krankenversicherung/hilfsmittel-wie-laeuft-die-versorgung-62299?utm_source=chatgpt.com">Consumer Advice Center</a> explicitly points out that this applies, for example, to oxygen devices.</p>
<h2 style="font-weight: 400;"><strong>How do I apply for a refund?</strong></h2>
<p style="font-weight: 400;">Reimbursement is not automatic. Those affected should therefore contact their health insurance provider directly and submit an application for coverage or reimbursement of the additional electricity costs.</p>
<p style="font-weight: 400;">The following information and supporting documents are generally required:</p>
<ul style="font-weight: 400;">
<li><strong>Device data:</strong> The exact name and type of the oxygen concentrator, as well as its power consumption (in watts).</li>
<li><strong>Service life:</strong> On average, how many hours per day is the device operated?</li>
<li><strong>Proof of operation:</strong> If applicable, the current operating hours of the device (readable via the device's counter).</li>
<li><strong>Electricity costs:</strong> A recent electricity bill showing the price per kilowatt hour.</li>
<li><strong>Supply:</strong> Proof that the oxygen device was prescribed by a doctor and approved by the health insurance company.</li>
<li><strong>No self-purchase:</strong> The device was provided by the health insurance company and not purchased privately.</li>
</ul>
<p style="font-weight: 400;">Health insurance companies handle reimbursement differently. Often, a fixed annual or monthly amount is paid. Some health insurance companies calculate the actual additional electricity costs based on the device's consumption and individual usage time.</p>
<p style="font-weight: 400;">You can usually submit your application informally or using a specific form from your health insurance provider (often available in their online member portal). Retroactive applications are generally possible for up to four years.</p>
<p style="font-weight: 400;">For those with private health insurance, potential cost coverage depends on the individual insurance contract and the agreed-upon terms and conditions. It is advisable to contact the private health insurance company directly for clarification.</p>
<h2 style="font-weight: 400;"><strong>Our tip</strong></h2>
<p style="font-weight: 400;">If you use an oxygen concentrator, don't simply accept the electricity costs as an unavoidable additional burden. Specifically ask your health insurance company about reimbursement for electricity costs associated with medical devices.</p>
<p style="font-weight: 400;">If the application is rejected, it is worthwhile to carefully examine the reasons given and, if necessary, file an appeal. The advice centers of social welfare organizations can also provide assistance with any questions.</p>
<p style="font-weight: 400;"><strong>Important:</strong> There is no general exemption from electricity costs for all users of an oxygen concentrator. The specific reimbursement and its amount must be clarified with the respective health insurance company.</p>
<p style="font-weight: 400;">More information is also available at: <a href="https://www.pflege.de/hilfsmittel/stromkostenerstattung/?teaser_id=83973&amp;teaser_position=Content&amp;post_id=search">https://www.pflege.de/hilfsmittel/stromkostenerstattung/?teaser_id=83973&amp;teaser_position=Content&amp;post_id=search</a></p>
<p style="font-weight: 400;"><p>The post <a href="https://alpha1-deutschland.org/en/stromkosten-fuer-den-sauerstoffkonzentrator">Stromkosten für den Sauerstoffkonzentrator</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Inkontinenz bei Alpha-1 – ein Tabuthema, über das wir sprechen sollten</title>
		<link>https://alpha1-deutschland.org/en/inkontinenz-bei-alpha-1-ein-tabuthema-ueber-das-wir-sprechen-sollten</link>
		
		<dc:creator><![CDATA[A1D-WebRedaktion]]></dc:creator>
		<pubDate>Mon, 16 Nov 2026 10:37:52 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<category><![CDATA[Hilfsmittel]]></category>
		<guid ispermalink="false">https://alpha1-deutschland.org/?p=7452</guid>

					<description><![CDATA[<p>Incontinence in Alpha-1 – a taboo subject we should discuss. Incontinence is a topic many people are reluctant to talk about. Yet, involuntary bladder or bowel emptying also affects...</p>
<p>The post <a href="https://alpha1-deutschland.org/en/inkontinenz-bei-alpha-1-ein-tabuthema-ueber-das-wir-sprechen-sollten">Inkontinenz bei Alpha-1 – ein Tabuthema, über das wir sprechen sollten</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></description>
										<content:encoded><![CDATA[<h1 style="font-weight: 400;"><strong>Incontinence in Alpha-1 – a taboo subject we should talk about.</strong></h1>
<p style="font-weight: 400;">Incontinence is a topic many people are reluctant to discuss. However, involuntary bladder or bowel emptying also affects people with chronic lung diseases – and can be an additional burden in everyday life, especially for Alpha-1 lung patients.</p>
<p style="font-weight: 400;">Alpha-1 antitrypsin deficiency does not directly cause incontinence. However, accompanying symptoms of the lung disease can increase the risk. Stress incontinence is particularly common: Frequent or violent coughing increases pressure in the abdominal cavity. If the pelvic floor muscles are weakened, this can lead to involuntary urine loss. Shortness of breath, limited mobility, and the associated difficulty in reaching a toilet in time can also play a role. Some affected individuals also develop a strong, sudden urge to urinate (urge incontinence).</p>
<p style="font-weight: 400;"><strong>What can help?</strong></p>
<p style="font-weight: 400;">Incontinence is not an unchangeable fate. There are various ways to alleviate the symptoms and improve quality of life:</p>
<ul style="font-weight: 400;">
<li><strong>Pelvic floor exercises:</strong> Targeted exercises can strengthen the pelvic floor muscles. Specialized physiotherapists can help ensure that the exercises are performed correctly and coordinated with breathing.</li>
<li><strong>Bladder training:</strong> For frequent urges to urinate, individually tailored toilet training can help improve bladder control.</li>
<li><strong>Treating a cough:</strong> Good management of the lung disease and the most effective possible treatment for secretions and coughs can reduce the pressure on the pelvic floor.</li>
<li><strong>Use resources:</strong> Pads and special incontinence products provide security in everyday life and allow continued social activities.</li>
<li><strong>Medical consultation:</strong> A general practitioner, urologist or gynecologist can clarify the causes and suggest further treatment options.</li>
</ul>
<h3 style="font-weight: 400;"><span style="color: #ff6600;"><strong>Important to know: You have a legal right to be supplied with incontinence products. A free guide and a <a style="color: #ff6600;" href="https://bvkm.de/ratgeber/inkontinenzversorgung/">Sample application</a> You can find more information here: <a style="color: #ff6600;" href="http://www.bvkm.de/">www.bvkm.de</a> under „Law &amp; Advice“ with the keyword „Incontinence Care”</strong></span></h3><p>The post <a href="https://alpha1-deutschland.org/en/inkontinenz-bei-alpha-1-ein-tabuthema-ueber-das-wir-sprechen-sollten">Inkontinenz bei Alpha-1 – ein Tabuthema, über das wir sprechen sollten</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>FIB-4: Ein weiterer einfacher Bluttest zur ersten Einschätzung der Leber</title>
		<link>https://alpha1-deutschland.org/en/fib-4-ein-weiterer-einfacher-bluttest-zur-ersten-einschaetzung-der-leber</link>
		
		<dc:creator><![CDATA[A1D-WebRedaktion]]></dc:creator>
		<pubDate>Tue, 10 Nov 2026 16:44:27 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<category><![CDATA[Alpha-1 & Leber]]></category>
		<category><![CDATA[Aus der Forschung]]></category>
		<guid ispermalink="false">https://alpha1-deutschland.org/?p=7447</guid>

					<description><![CDATA[<p>FIB-4: Another simple blood test for an initial assessment of liver health. Liver fibrosis often develops over years without those affected noticing any symptoms. Especially in cases of alpha-1 antitrypsin deficiency, it is therefore important to...</p>
<p>The post <a href="https://alpha1-deutschland.org/en/fib-4-ein-weiterer-einfacher-bluttest-zur-ersten-einschaetzung-der-leber">FIB-4: Ein weiterer einfacher Bluttest zur ersten Einschätzung der Leber</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></description>
										<content:encoded><![CDATA[<h2 style="font-weight: 400;"><strong>FIB-4: Another simple blood test for an initial assessment of the liver</strong></h2>
<p style="font-weight: 400;">Liver fibrosis often develops over years without those affected noticing any symptoms. Especially in cases of alpha-1 antitrypsin deficiency, it is therefore important to monitor liver function regularly. In addition to measuring liver stiffness (LSM) with a FibroScan®, certain blood tests can help assess the risk of advanced liver fibrosis.</p>
<p style="font-weight: 400;">In addition to the APRI index already described on our homepage, one such blood test is the so-called <strong>FIB-4 Index</strong>.</p>
<p style="font-weight: 400;"><strong>What is the FIB-4 index?</strong></p>
<p style="font-weight: 400;">The FIB-4 index (Fibrose-4 index or Fibrose-4 score) is an easily calculated value that combines four pieces of information:</p>
<ul style="font-weight: 400;">
<li>Old</li>
<li>GOT (AST)</li>
<li>GPT (ALT)</li>
<li>Number of blood platelets (thrombocytes)</li>
</ul>
<p style="font-weight: 400;">These values are taken from a routine blood test. The FIB-4 can therefore provide an initial indication of whether further liver examination is advisable.</p>
<p style="font-weight: 400;">FIB-4 has also been studied in people with alpha-1 antitrypsin deficiency. Recent data show that it can be particularly helpful in... <strong>to rule out advanced liver fibrosis</strong>, if no liver stiffness measurement is available.</p>
<p style="font-weight: 400;"><strong>How do I calculate FIB-4?</strong></p>
<p style="font-weight: 400;">The FIB-4 is calculated from age, GOT (AST), GPT (ALT), and platelet count. The calculation can be performed using an online calculator, for example, one found at the Liver Foundation website:</p>
<p style="font-weight: 400;"><strong>FIB-4 computer:</strong> https://www.leberhilfe.org/fib-4-rechner/</p>
<p style="font-weight: 400;"><strong>What does my result mean?</strong></p>
<p style="font-weight: 400;">The FIB-4 is <strong>no proof for or against liver fibrosis</strong>. It serves primarily as a guide.</p>
<p style="font-weight: 400;">In people with alpha-1 antitrypsin deficiency, and especially in those with <strong>Pi*ZZ genotype</strong> An abnormal FIB-4 value should be discussed with the treating physician. A recent study of 362 Pi*ZZ patients showed that a <strong>FIB-4 value below 1.79</strong> Advanced liver fibrosis or cirrhosis could be ruled out with a high degree of probability if no transient elastography was available.</p>
<p style="font-weight: 400;">Important: <strong>A low FIB-4 value does not replace regular liver monitoring.</strong> The FIB-4 can provide an initial indication, but a more precise assessment of liver fibrosis is preferably carried out by measuring liver stiffness (FibroScan®).</p>
<p style="font-weight: 400;"><strong>Our goal: To detect changes early</strong></p>
<p style="font-weight: 400;">We want to detect potential liver fibrosis early, not just when cirrhosis has already developed. Therefore, people with alpha-1 antitrypsin deficiency, in particular, should have their liver checked regularly. The FIB-4 test can be a simple additional tool in this process – along with blood tests, ultrasound, and especially liver stiffness measurement. Please feel free to contact us if you have elevated levels.</p>
<p style="font-weight: 400;">Prof. Pavel Strnad (Email to <a href="mailto:alpha1@ukaachen.de">alpha1@ukaachen.de</a>) and Marion Wilkens</p>
<p style="font-weight: 400;"><p>The post <a href="https://alpha1-deutschland.org/en/fib-4-ein-weiterer-einfacher-bluttest-zur-ersten-einschaetzung-der-leber">FIB-4: Ein weiterer einfacher Bluttest zur ersten Einschätzung der Leber</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Alpha1-Journal: Ausgabe 1/2026</title>
		<link>https://alpha1-deutschland.org/en/alpha1-journal-ausgabe-1-2026</link>
		
		<dc:creator><![CDATA[Redaktion Alpha1 Deutschland e.V.]]></dc:creator>
		<pubDate>Wed, 30 Sep 2026 15:35:11 +0000</pubDate>
				<category><![CDATA[Alpha1-Journal]]></category>
		<guid ispermalink="false">https://alpha1-deutschland.org/?p=7416</guid>

					<description><![CDATA[<p>The post <a href="https://alpha1-deutschland.org/en/alpha1-journal-ausgabe-1-2026">Alpha1-Journal: Ausgabe 1/2026</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div id="fws_6afcbd97a93ed"  data-column-margin="none" data-midnight="dark" data-bottom-percent="4%"  class="wpb_row vc_row-fluid vc_row top-level full-width-section vc_row-o-equal-height vc_row-flex vc_row-o-content-middle"  style="padding-top: 0px; padding-bottom: calc(100vw * 0.04); "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div style="" class="vc_col-sm-7 wpb_column column_container vc_column_container col padding-12-percent inherit_tablet inherit_phone flex_gap_desktop_10px" data-using-bg="true" data-padding-pos="all" data-has-bg-color="true" data-bg-color="#91d8ff" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" ><div class="column-bg-overlay-wrap column-bg-layer" data-bg-animation="none"><div class="column-bg-overlay" style="opacity: 1; background-color: #91d8ff;"></div></div>
			<div class="wpb_wrapper">
				<div id="fws_6afcbd97aa2ab" data-midnight="" data-column-margin="default" class="wpb_row vc_row-fluid vc_row inner_row"  style=""><div class="row-bg-wrap"> <div class="row-bg" ></div> </div><div class="row_col_wrap_12_inner col span_12  left">
	<div  class="vc_col-sm-12 vc_col-lg-11 vc_col-md-11 vc_col-xs-12 wpb_column column_container vc_column_container col child_column no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"   data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
		<div class="wpb_wrapper">
			
<div class="wpb_text_column wpb_content_element  vc_custom_1790781214477" >
	<p><strong>Alpha1 Journal Issue 1/2026</strong></p>
</div>




		</div> 
	</div>
	</div> 
</div></div><div id="fws_6afcbd97aaec6" data-midnight="" data-column-margin="none" class="wpb_row vc_row-fluid vc_row inner_row"  style="padding-bottom: 10px; "><div class="row-bg-wrap"> <div class="row-bg" ></div> </div><div class="row_col_wrap_12_inner col span_12  left">
	<div  class="vc_col-sm-12 vc_col-lg-11 vc_col-md-11 vc_col-xs-12 wpb_column column_container vc_column_container col child_column no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"   data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
		<div class="wpb_wrapper">
			<div class="nectar-split-heading" data-align="default" data-m-align="inherit" data-text-effect="default" data-animation-type="line-reveal-by-space" data-animation-delay="0" data-animation-offset="" data-m-rm-animation="" data-stagger="" data-custom-font-size="false" ><h1 >From a small group of affected individuals to the largest Alpha-1 patient organization in Europe – 25 years of Alpha1 Germany</h1></div>
		</div> 
	</div>
	</div> 
</div></div><div id="fws_6afcbd97aba09" data-midnight="" data-column-margin="default" class="wpb_row vc_row-fluid vc_row inner_row"  style=""><div class="row-bg-wrap"> <div class="row-bg" ></div> </div><div class="row_col_wrap_12_inner col span_12  left">
	<div style="margin-top: 5%; " class="vc_col-sm-12 vc_col-lg-11 vc_col-md-11 vc_col-xs-12 wpb_column column_container vc_column_container col child_column no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"   data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
		<div class="wpb_wrapper">
			
<div class="wpb_text_column wpb_content_element  vc_custom_1790781373509" >
	<p>This issue contains:</p>
<ul>
<li>New COPD guideline: Alpha-1 test recommended for all COPD patients</li>
<li>Information Day 2026: 25 Years of Community, Knowledge and Mutual Help</li>
<li>Alpha-1 History Video: When Medical History Comes Alive</li>
<li>From Heidelberg to Regensburg: Alpha-1 knowledge on site</li>
</ul>
</div>




		</div> 
	</div>
	</div> 
</div></div>
			</div> 
		</div>
	</div> 

	<div  class="vc_col-sm-5 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				<div id="fws_6afcbd97aca36" data-midnight="" data-column-margin="default" class="wpb_row vc_row-fluid vc_row inner_row"  style=""><div class="row-bg-wrap"> <div class="row-bg" ></div> </div><div class="row_col_wrap_12_inner col span_12  left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col child_column no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"   data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
		<div class="wpb_wrapper">
			<div class="img-with-aniamtion-wrap right" data-max-width="110%" data-max-width-mobile="default" data-shadow="none" data-animation="grow-in" >
      <div class="inner">
        <div class="hover-wrap"> 
          <div class="hover-wrap-inner">
            <a href="https://alpha1-deutschland.org/wp-content/uploads/Alpha1-Journal-1-2026.jpg" class="pp right" title="">
              <img fetchpriority="high" decoding="async" class="img-with-animation skip-lazy" data-delay="0" height="1219" width="878" data-animation="grow-in" src="https://alpha1-deutschland.org/wp-content/uploads/Alpha1-Journal-1-2026.jpg" alt="Cover digitales Alpha-1-Journal 1/2026" srcset="https://alpha1-deutschland.org/wp-content/uploads/Alpha1-Journal-1-2026.jpg 878w, https://alpha1-deutschland.org/wp-content/uploads/Alpha1-Journal-1-2026-216x300.jpg 216w, https://alpha1-deutschland.org/wp-content/uploads/Alpha1-Journal-1-2026-738x1024.jpg 738w, https://alpha1-deutschland.org/wp-content/uploads/Alpha1-Journal-1-2026-768x1066.jpg 768w, https://alpha1-deutschland.org/wp-content/uploads/Alpha1-Journal-1-2026-9x12.jpg 9w" sizes="(max-width: 878px) 100vw, 878px" />
            </a>
          </div>
        </div>
         
      </div>
      </div>
		</div> 
	</div>
	</div> 
</div></div>
			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97ae41e"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element" >
	<h2><span style="color: #004267;">Flippingbook</span></h2>
</div>




	<div class="wpb_raw_code wpb_raw_html wpb_content_element" >
		<div class="wpb_wrapper">
			<a href="https://online.flippingbook.com/view/828765999/" class="fbo-embed" data-fbo-id="0499b5aef2" data-fbo-ratio="3:2" data-fbo-lightbox="yes" data-fbo-width="100%" data-fbo-height="auto" data-fbo-version="1" style="max-width: 100%">Alpha1 Journal Issue 1 | 2026</a><script async defer src="https://online.flippingbook.com/EmbedScriptUrl.aspx?m=redir&hid=828765999"></script>
		</div>
	</div>

			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97af6f8"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				<div class="nectar-split-heading" data-align="default" data-m-align="inherit" data-text-effect="none" data-animation-type="line-reveal-by-space" data-animation-delay="0" data-animation-offset="" data-m-rm-animation="" data-stagger="" data-custom-font-size="false" ><h2 >In this issue</h2></div>
<div class="wpb_text_column wpb_content_element" >
	<p>03 Preface<br />
06 Service: Board of Directors &amp; Advisory Board<br />
10 25 Years of Alpha1 Germany e. V. – Strong together for people with Alpha-1</p>
<h3>FEATURED:</h3>
<p>12 The Decade of the Lungs: For Lung Health in Germany<br />
14. Introduction of our two new scientific advisory boards</p>
<h3>ON OUR OWN BEHALF</h3>
<p>15 Upcoming Dates<br />
16 Alpha-1 History Videos: When Medical History Comes Alive<br />
20 From the German board to Europe: Thank you, Heinz Stutzenberger<br />
21 Journal, now only DIGITAL<br />
22 New guide: The path to a severely disabled person&#039;s ID card – explained in an easy-to-understand way<br />
23 Running together for Alpha-1 – A look back at the Rare Diseases Run 2026</p>
<h3>DOCUMENTED FOR YOU:</h3>
<p>25 Giving and receiving help: A special information day<br />
27. Lecture by Dr. Marc Lepiorz: The Knowledge Quiz: General Information and More about Alpha-1<br />
31 Lecture by Markus Baltensperger: Singing as Therapy<br />
33 Prof. Dr. Pavel Strnad: Perspectives: Alpha1 and the liver<br />
36 Current News Items – from new therapies to click rates and AI to chatbots<br />
38 children and adolescents with Alpha-1 Antitrypsin Deficiency (AATD)<br />
43 Personal experiences: The mere thought takes her breath away<br />
44 Lungs and psyche: The psyche breathes along with<br />
49 Air to live<br />
52 What the Abyss Teaches Us About Life</p>
<h3>HELP FOR RELATIVES:</h3>
<p>54 Support for relatives of people with alpha-1 antitrypsin deficiency</p>
<h3>ALPHA1 ON THE ROAD:</h3>
<p>56 Alpha1 Germany at the DGP Congress in Munich<br />
58 New COPD guideline: Important step for the early detection of alpha-1 antitrypsin deficiency<br />
59th DGIM Congress 2026 in Wiesbaden – Internal Medicine in Transition<br />
60th World Bronchiectasis Conference 2026 in Hanover – ten years of international exchange for better care<br />
61 My Day in Front of the Camera<br />
63 COPD research in transition: Individualized diagnosis and treatment</p>
<h3>FROM ALPHAS FOR ALPHAS:</h3>
<p>64 Alpha1 Germany e. V. in conversation: Who are you beyond the diagnosis, Sabine?<br />
67 Learn self-management – INSEA gives courage for everyday life</p>
<h3>MISCELLANEOUS:</h3>
<p>68 Courageously speaking about bullying – Sandra Böhmer in the Alpha-Cast</p>
<h3>FROM THE Self-Help Groups:</h3>
<p>69 The 4th Patient Day at the Thorax Clinic Heidelberg<br />
71st AlphaCare Regional Day in cooperation with Alpha1 Germany and the SHG Region Trier<br />
72nd Patient Day in Regensburg – Knowledge, exchange and a special setting<br />
74 IRMA in Hamburg<br />
75 Further information from the self-help groups</p>
<h3>ALPHA1 INTERNATIONAL:</h3>
<p>76 Alpha1 Germany traveling in Europe<br />
79 highlights from the work of the Alpha-1 Europe Alliance in the first half of 2026<br />
81 Memory Exercise</p>
<h3>FROM RESEARCH:</h3>
<p>82 Continuing education (for doctors) up to date – Knowledge about Alpha-1 now also available as a podcast<br />
83 Your experience is needed!</p>
<h3>LETTERS TO THE EDITOR:</h3>
<p>84</p>
</div>




			</div> 
		</div>
	</div> 
</div></div><p>The post <a href="https://alpha1-deutschland.org/en/alpha1-journal-ausgabe-1-2026">Alpha1-Journal: Ausgabe 1/2026</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Luft zum Leben</title>
		<link>https://alpha1-deutschland.org/en/luft-zum-leben-alpha1-deutschland</link>
		
		<dc:creator><![CDATA[Redaktion Alpha1 Deutschland e.V.]]></dc:creator>
		<pubDate>Wed, 30 Sep 2026 12:51:39 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<category><![CDATA[Alpha1-Journal]]></category>
		<category><![CDATA[Sauerstoff]]></category>
		<guid ispermalink="false">https://alpha1-deutschland.org/?p=7407</guid>

					<description><![CDATA[<p>The post <a href="https://alpha1-deutschland.org/en/luft-zum-leben-alpha1-deutschland">Luft zum Leben</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div id="fws_6afcbd97b94c3"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row full-width-section"  style="padding-top: 0px; padding-bottom: 50px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				<div class="vc_separator wpb_content_element vc_separator_align_center vc_sep_border_width_5 vc_sep_pos_align_center wpb_content_element vc_separator-has-text"   style="width: 100%;"><span class="vc_sep_holder vc_sep_holder_l"><span class="vc_sep_line"></span></span><h4>Author</h4><span class="vc_sep_holder vc_sep_holder_r"><span class="vc_sep_line"></span></span>
</div>
<div class="wpb_text_column wpb_content_element" >
	<p style="font-weight: 400;"><strong>Gabi Niethammer, as appeared in <a href="https://alpha1-deutschland.org/en/alpha1-journal/">Alpha1 Journal 1/2026</a>.</strong></p>
</div>



<div class="divider-wrap" data-alignment="default"><div style="margin-top: 25px; height: 5px; margin-bottom: 25px;" data-width="100%" data-animate="" data-animation-delay="" data-color="default" class="divider-border"></div></div>
<div class="wpb_text_column wpb_content_element" >
	<p>For proper breathing to function, two systems must work together: the lungs, where gas exchange takes place, and the respiratory pump, which enables the ventilation of the lungs.</p>
<p>The lungs transport air and oxygen; the actual gas exchange takes place in the alveoli: oxygen is absorbed from the inhaled air into the blood and carbon dioxide (CO2), a metabolic product of our body, is released via the lungs.</p>
<p>We need the respiratory pump to get air into our lungs and enable gas exchange. It includes the respiratory center, the bony rib cage (which transmits force), the respiratory muscles in the chest, and the diaphragm.</p>
<p>A disorder can occur in both the lungs (pulmonary insufficiency) and the respiratory pump (ventilatory insufficiency).</p>
<p>Pulmonary insufficiency can be diagnosed by measuring blood gases, for example, at the earlobe. If the oxygen levels or partial pressure of oxygen in the blood are reduced, while the CO2 level is normal, this indicates that gas exchange is impaired. The CO2 level can be normal or reduced. This occurs due to an increased respiratory rate when we try to improve oxygen uptake. This simultaneously leads to more CO2 being exhaled, which can result in a lower CO2 level.</p>
<p>Ventilatory insufficiency occurs when lung ventilation is no longer adequate, causing the CO2 level in the blood to rise. This is usually due to respiratory muscle fatigue, preventing sufficient CO2 expulsion. As a result, the carbon dioxide concentration in the blood increases; often, oxygen supply is also impaired, leading to respiratory muscle strain.</p>
<p>Depending on the disorder, there are different treatment approaches: In the case of pulmonary insufficiency, i.e., a disorder of gas exchange, oxygen therapy may be useful.</p>
<p>In cases of ventilatory insufficiency, where lung ventilation is impaired, mask ventilation – often at night – can be used. It supports breathing and relieves the strain on the respiratory muscles.</p>
<p>This presentation focuses on oxygen therapy. A fundamental distinction is made between two forms of hypoxemia: Chronic hypoxemia describes a persistently low oxygen level in the blood. In contrast, exercise-induced hypoxemia is characterized by oxygen deficiency only during physical exertion.</p>
<p>To assess whether oxygen therapy could be beneficial, the existing treatment is first reviewed. Oxygen therapy can only be considered if the underlying condition is adequately treated, meaning medication and inhalation are optimally coordinated, and hypoxemia still persists. Further investigations will determine whether there is a chronic or exercise-induced oxygen deficiency in the blood.</p>
<p>Long-term oxygen therapy (LTOT) should be used for at least 15 hours daily, ideally longer. This is usually achieved through a combination of stationary oxygen supply at home and a portable oxygen concentrator. The goal is to ensure adequate oxygenation of the body and to maintain, and ideally even improve, mobility and quality of life.</p>
</div>




			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97baa0a"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				<div class="divider-wrap" data-alignment="center"><div style="margin-top: 25px; width: 20%; height: 2px; margin-bottom: 25px;" data-width="20%" data-animate="" data-animation-delay="" data-color="accent-color" class="divider-small-border"></div></div><div class="img-with-aniamtion-wrap center" data-max-width="100%" data-max-width-mobile="default" data-shadow="none" data-animation="none" >
      <div class="inner">
        <div class="hover-wrap"> 
          <div class="hover-wrap-inner">
            <img decoding="async" class="img-with-animation skip-lazy" data-delay="0" height="1687" width="2560" data-animation="none" src="https://alpha1-deutschland.org/wp-content/uploads/langzeit-sauerstofftherapie-entscheidungsweg-scaled.jpg" alt="Entscheidungsweg zur Langzeit-Sauerstofftherapie mit Kriterien für Sauerstoffgabe bei Hypoxämie in Ruhe, unter Belastung und im Schlaf." srcset="https://alpha1-deutschland.org/wp-content/uploads/langzeit-sauerstofftherapie-entscheidungsweg-scaled.jpg 2560w, https://alpha1-deutschland.org/wp-content/uploads/langzeit-sauerstofftherapie-entscheidungsweg-300x198.jpg 300w, https://alpha1-deutschland.org/wp-content/uploads/langzeit-sauerstofftherapie-entscheidungsweg-1024x675.jpg 1024w, https://alpha1-deutschland.org/wp-content/uploads/langzeit-sauerstofftherapie-entscheidungsweg-768x506.jpg 768w, https://alpha1-deutschland.org/wp-content/uploads/langzeit-sauerstofftherapie-entscheidungsweg-1536x1012.jpg 1536w, https://alpha1-deutschland.org/wp-content/uploads/langzeit-sauerstofftherapie-entscheidungsweg-2048x1350.jpg 2048w, https://alpha1-deutschland.org/wp-content/uploads/langzeit-sauerstofftherapie-entscheidungsweg-18x12.jpg 18w" sizes="(max-width: 2560px) 100vw, 2560px" />
          </div>
        </div>
        
      </div>
    </div><div class="divider-wrap" data-alignment="center"><div style="margin-top: 25px; width: 20%; height: 2px; margin-bottom: 25px;" data-width="20%" data-animate="" data-animation-delay="" data-color="accent-color" class="divider-small-border"></div></div>
			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97bcab1"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element" >
	<p>Oxygen support during physical exertion is used when the body&#039;s oxygen demand increases during activity, leading to an oxygen deficiency, for example, during a walk, at the gym, or during other everyday activities. It&#039;s important to note that with this form of hypoxemia, there is usually no significant impairment of oxygen supply at rest. The goal is to improve oxygen saturation during exertion, potentially alleviate shortness of breath, and increase physical performance, which in turn can have a positive impact on mobility and quality of life.</p>
<p>If an oxygen deficiency is detected, the necessary oxygen flow rate for adequate oxygenation must be individually determined. The goal is to achieve a partial pressure of oxygen (PaO2) of at least approximately 60 mmHg. Millimeters of mercury (mmHg) are the unit of measurement for the partial pressure of oxygen in the blood.</p>
<p>Oxygen supply is assessed either by measuring blood gases, for example at the earlobe, or using a pulse oximeter on the finger. An oxygen saturation of approximately 90–92 mg/dL is often sufficient; however, target values can vary from person to person and are determined in consultation with the treating physician.</p>
<p>It should be noted that the required flow rate at rest during the day may differ from that during physical exertion or at night. Oxygen supply must therefore be adjusted to individual needs; personal activity levels and living conditions also play an important role.</p>
<p>Changes in physical condition may necessitate adjustments to both oxygen requirements and the device. For example, if oxygen was temporarily prescribed in an acute situation, such as due to an infection or hospitalization, it is possible that no additional oxygen supply will be needed after recovery.</p>
<p>Firstly, there is stationary oxygen supply, which distinguishes between liquid oxygen and stationary oxygen concentrators.</p>
<h2><span style="color: #004267;">Liquid oxygen </span></h2>
<ul>
<li>Advantages: Quiet; independent of mains power; also suitable for higher oxygen flow rates.</li>
<li>Special features: The supply is provided via a stationary tank, which is regularly filled by the supplier.</li>
</ul>
<h2><span style="color: #004267;">Oxygen concentrators </span></h2>
<ul>
<li>Advantages: No oxygen supply required;<br />
Mostly easy to handle.</li>
<li>Special features: Noise level; power consumption; regular maintenance required; the maximum possible oxygen output depends on the device.</li>
</ul>
<p>Secondly, there is the supply of mobile devices.</p>
<p>Oxygen flow rates are often measured in stages rather than liters per minute, meaning that, for example, stage 2 does not automatically translate to 2 liters. Therefore, it is crucial to know which device setting corresponds to the prescribed oxygen flow rate. Furthermore, these stages can vary between manufacturers. It is essential that the oxygen supply is individually tailored to the specific device and that the oxygen delivery is regularly monitored.</p>
<p>There are different mobile supply options:</p>
<ul>
<li>Mobile liquid oxygen units that are filled at the stationary tank</li>
<li>Mobile oxygen concentrators, for example for pulling or carrying</li>
</ul>
<p>It should be determined whether continuous oxygen therapy is necessary or whether breath-controlled oxygen delivery (demand system) is sufficient. This technique can conserve oxygen and extend the operating time of mobile devices.</p>
<p>The evidence for oxygen therapy varies considerably across different questions, making individualized consultation and adjustment of care particularly important. In practice, it is evident that those affected are not always adequately informed about their care or trained in the use of the device. As a result, some patients feel ill-prepared for everyday life and perceive portable oxygen devices, in particular, as a burden rather than a support.</p>
<p>There are various treatment options available. Crucially, good communication between patients and healthcare providers is essential to best align the device requirements with individual life circumstances.</p>
<p>In a direct comparative study of continuous-flow and demand-side oxygen systems under stress in COPD patients with hypoxemia, a continuous-flow liquid oxygen device, a liquid oxygen device with a demand-side system, and a concentrator with a demand-side system were examined at the Schön Clinic Berchtesgadener Land. Differences between the devices were expected. On average, however, comparable results were observed with regard to oxygen saturation and walking performance. In contrast, significant differences between the devices were found in individual participants. This underscores the importance of individually testing oxygen systems to achieve the most suitable oxygen supply.</p>
</div>




			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97bda82"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element" >
	<h2><span style="color: #004267;">What are the future prospects? </span></h2>
<p>Research is already underway on automated oxygen systems. These systems continuously measure oxygen demand and adjust oxygen delivery to achieve the most stable oxygen supply possible or a defined target oxygen saturation range.</p>
<p>A study conducted by the Schön Clinic compared this procedure with constant, guideline-compliant oxygen administration. The results showed a significant increase in walking distance with automatic oxygen administration. At the same time, participants had to abandon the exercise test less frequently due to shortness of breath. In the subsequent survey, the majority expressed a preference for automatic oxygen administration.</p>
<p>Although automatic oxygen systems are currently used predominantly in clinical and scientific settings, individually tailored oxygen supply remains crucial.</p>
<p>In summary: Whether, when, and in what form oxygen therapy is appropriate must be assessed individually and coordinated with the treating physician. The goal is to provide care that is precisely tailored to where it is needed, thus maintaining or improving mobility and quality of life as much as possible.</p>
<p>And after all this information about oxygen, equipment and supplies, perhaps one thing should not be missing at the end: a chance to take a deep breath.</p>
<p>The Pneumo-Factory has developed several short videos on this topic. They focus on our breathing in everyday life – how natural breathing works, how we can become more aware of it, and how we can experience and use it, for example, in singing together.</p>
</div>




			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97be958"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				<div class="divider-wrap" data-alignment="center"><div style="margin-top: 25px; width: 20%; height: 2px; margin-bottom: 25px;" data-width="20%" data-animate="" data-animation-delay="" data-color="accent-color" class="divider-small-border"></div></div><div class="img-with-aniamtion-wrap center" data-max-width="100%" data-max-width-mobile="default" data-shadow="none" data-animation="none" >
      <div class="inner">
        <div class="hover-wrap"> 
          <div class="hover-wrap-inner">
            <img decoding="async" class="img-with-animation skip-lazy" data-delay="0" height="477" width="800" data-animation="none" src="https://alpha1-deutschland.org/wp-content/uploads/pneumo-factory-videos-online-training.jpg" alt="Frau schaut am Laptop ein Trainingsvideo der Pneumo Factory für Menschen mit Lungenerkrankungen." srcset="https://alpha1-deutschland.org/wp-content/uploads/pneumo-factory-videos-online-training.jpg 800w, https://alpha1-deutschland.org/wp-content/uploads/pneumo-factory-videos-online-training-300x179.jpg 300w, https://alpha1-deutschland.org/wp-content/uploads/pneumo-factory-videos-online-training-768x458.jpg 768w, https://alpha1-deutschland.org/wp-content/uploads/pneumo-factory-videos-online-training-18x12.jpg 18w" sizes="(max-width: 800px) 100vw, 800px" />
          </div>
        </div>
        
      </div>
    </div><div class="divider-wrap" data-alignment="center"><div style="margin-top: 40px; width: 20%; height: 2px; margin-bottom: 40px;" data-width="20%" data-animate="" data-animation-delay="" data-color="accent-color" class="divider-small-border"></div></div>
			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97c03f2"  data-column-margin="default" data-midnight="light"  class="wpb_row vc_row-fluid vc_row has-row-bg-color  right_padding_30px left_padding_30px"  style="padding-top: 30px; padding-bottom: 30px; --row-bg-color: #004267;"><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop using-bg-color"  style="background-color: #004267; "></div></div></div><div class="row_col_wrap_12 col span_12 light left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element" >
	<h2>Discover it now.</h2>
<p>&nbsp;</p>
<p>Click here to access the Pneumo-Factory videos:</p>
</div>



<a class="nectar-button large regular accent-color  regular-button"  role="button" style="margin-top: 50px; margin-bottom: 50px; " target="_blank" href="https://www.pneumo-factory.de/#videos" data-color-override="false" data-hover-color-override="false" data-hover-text-color-override="#fff"><span>MORE INFORMATION</span></a>
			</div> 
		</div>
	</div> 
</div></div><p>The post <a href="https://alpha1-deutschland.org/en/luft-zum-leben-alpha1-deutschland">Luft zum Leben</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Ankündigung zum 2. Treffen der SHG Rhein-Neckar-Odenwald</title>
		<link>https://alpha1-deutschland.org/en/ankuendigung-zum-2-treffen-der-shg-rhein-neckar-odenwald</link>
		
		<dc:creator><![CDATA[A1D-WebRedaktion]]></dc:creator>
		<pubDate>Mon, 28 Sep 2026 16:03:09 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<category><![CDATA[Gruppentreffen]]></category>
		<category><![CDATA[SHG Rhein-Neckar-Odenwald]]></category>
		<guid ispermalink="false">https://alpha1-deutschland.org/?p=7393</guid>

					<description><![CDATA[<p>Hello everyone, our first meeting on July 18, 2026, was very well received. We discussed meeting again in the fall, and now it&#039;s finally happening...</p>
<p>The post <a href="https://alpha1-deutschland.org/en/ankuendigung-zum-2-treffen-der-shg-rhein-neckar-odenwald">Ankündigung zum 2. Treffen der SHG Rhein-Neckar-Odenwald</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p style="font-weight: 400;"><strong>Hello, my dears,</strong></p>
<p style="font-weight: 400;">Our first meeting on July 18, 2026, was very well received. We then discussed meeting again in the fall.</p>
<p style="font-weight: 400;"><strong>Now the time has come:</strong></p>
<p style="font-weight: 400;"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4c5.png" alt="📅" class="wp-smiley" style="height: 1em; max-height: 1em;" /> <strong>Saturday, October 24, 2026 at 1:30 PM</strong></p>
<p style="font-weight: 400;"><img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f4cd.png" alt="📍" class="wp-smiley" style="height: 1em; max-height: 1em;" /> <strong>Caritas at Heppenheim Monastery</strong><br />
Kalterer Straße 3<br />
64646 Heppenheim</p>
<p style="font-weight: 400;">The monastery is located directly opposite the train station.</p>
<p style="font-weight: 400;"><strong>Oxygen – Systems, devices and possibilities in everyday life</strong></p>
<p style="font-weight: 400;">We are very pleased that we <strong>Dirk Filkorn from Oxycare</strong> were able to secure them as speakers.</p>
<p style="font-weight: 400;">He will tell us all about the topic <strong>Oxygen supply</strong> inform, among other things:</p>
<ul style="font-weight: 400;">
<li>What oxygen systems and devices are available?</li>
<li>Liquid oxygen or concentrator – what are the differences?</li>
<li>What should you consider when choosing a system and a provider?</li>
<li>Handling and use of oxygen in everyday life</li>
<li>What options are there for travel and on the go?</li>
<li>Which systems are suitable for which needs?</li>
</ul>
<p style="font-weight: 400;">After the presentation, we can meet at <strong>Coffee and cake</strong> To comfortably exchange ideas, update each other, stroll around and of course have fun. <img src="https://s.w.org/images/core/emoji/17.0.2/72x72/1f60a.png" alt="😊" class="wp-smiley" style="height: 1em; max-height: 1em;" /></p>
<p style="font-weight: 400;"><strong>Unfortunately, we were then unable to go to Starkenburg again.</strong></p>
<p style="font-weight: 400;">Since we unfortunately can&#039;t make it to Starkenburg again, we end our day, as last time, by going to the &quot;Halber Mond&quot; restaurant, which is within walking distance.</p>
<p style="font-weight: 400;">Please understand that the food there <strong>It must be paid for privately</strong></p>
<p style="font-weight: 400;"><strong>Please give us feedback as soon as possible.</strong></p>
<p style="font-weight: 400;">We would be very happy if many of you could join us again. <img src="https://s.w.org/images/core/emoji/17.0.2/72x72/2764.png" alt="❤" class="wp-smiley" style="height: 1em; max-height: 1em;" /></p>
<p style="font-weight: 400;">For better planning, we ask you to <strong>timely feedback</strong>, – also important for Mr. Filkorn – <strong>with how many people</strong> You&#039;re coming. Of course, we&#039;d love to see you again with family, friends, and anyone who&#039;s interested.</p>
<p style="font-weight: 400;">You can also send us your <strong>Questions or desired topics related to oxygen</strong> If you inform us, Mr. Filkorn could then take this into account in his preparation.<strong>.</strong></p>
<p>&nbsp;</p>
<p style="font-weight: 400;"><strong>One more small note regarding accessibility:</strong><br />
The freight elevator is expected to be repaired at that time. However, we will find another solution. Based on the current situation, this would likely involve approximately... <strong>5 steps</strong> to manage. Hopefully, that should be doable for most of us.</p>
<p>&nbsp;</p>
<p style="font-weight: 400;">As a reminder, we will contact you again shortly before the meeting.</p>
<p style="font-weight: 400;">We are really looking forward to a lovely afternoon together with you!</p>
<p style="font-weight: 400;">Best regards</p>
<p style="font-weight: 400;">Christine Stukan<br />
Luise Behrens<br />
Group leader SHG Rhein-Neckar-Odenwald<br />
(Alpha1-Deutschland eV)<br />
Mail: <a href="mailto:shg.rhein-neckar-odenwald@alpha1-deutschland.org">shg.rhein-neckar-odenwald@alpha1-deutschland.org</a><br />
Phone:<br />
+49 1525 41117320<br />
+49 171 8241186</p><p>The post <a href="https://alpha1-deutschland.org/en/ankuendigung-zum-2-treffen-der-shg-rhein-neckar-odenwald">Ankündigung zum 2. Treffen der SHG Rhein-Neckar-Odenwald</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Bericht vom 1. Treffen der SHG Rhein-Neckar-Odenwald</title>
		<link>https://alpha1-deutschland.org/en/bericht-vom-1-treffen-der-shg-rhein-neckar-odenwald</link>
		
		<dc:creator><![CDATA[A1D-WebRedaktion]]></dc:creator>
		<pubDate>Mon, 28 Sep 2026 15:45:18 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<category><![CDATA[Gruppentreffen]]></category>
		<category><![CDATA[SHG Rhein-Neckar-Odenwald]]></category>
		<guid ispermalink="false">https://alpha1-deutschland.org/?p=7389</guid>

					<description><![CDATA[<p>We did it! The first meeting of our self-help group took place on July 18, 2026. We met at the Heppenheim Monastery, in the premises of Caritas. We were very pleased that...</p>
<p>The post <a href="https://alpha1-deutschland.org/en/bericht-vom-1-treffen-der-shg-rhein-neckar-odenwald">Bericht vom 1. Treffen der SHG Rhein-Neckar-Odenwald</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><img decoding="async" class="alignnone size-medium wp-image-7405" src="https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_C-300x249.jpeg" alt="" width="300" height="249" srcset="https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_C-300x249.jpeg 300w, https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_C-1024x850.jpeg 1024w, https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_C-768x638.jpeg 768w, https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_C-14x12.jpeg 14w, https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_C.jpeg 1354w" sizes="(max-width: 300px) 100vw, 300px" /></p>
<p style="font-weight: 400;">We made it!</p>
<p style="font-weight: 400;">The first meeting of our self-help group took place on July 18, 2026.</p>
<p style="font-weight: 400;">We met at the Heppenheim Monastery, in the premises of Caritas.</p>
<p style="font-weight: 400;">We were very pleased that so many of us turned up – despite the date being in the middle of the holiday season.</p>
<p style="font-weight: 400;">The focus of our meeting was initially on getting to know each other, personal exchange, and sharing our own experiences on various topics.</p>
<p style="font-weight: 400;">First we <strong>us </strong>and <strong>our motivation</strong> presented for the self-help group.</p>
<p style="font-weight: 400;"><img decoding="async" class="alignnone size-medium wp-image-7404" src="https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_B-225x300.jpeg" alt="" width="225" height="300" srcset="https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_B-225x300.jpeg 225w, https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_B-768x1024.jpeg 768w, https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_B-1152x1536.jpeg 1152w, https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_B-9x12.jpeg 9w, https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_B.jpeg 1200w" sizes="(max-width: 225px) 100vw, 225px" /></p>
<p style="font-weight: 400;">Afterwards, each person shared a little about themselves, their medical history, and their experiences. It was also touching and enriching to hear the perspectives and experiences of the family members. Overall, this session was very interesting and very emotional.</p>
<p style="font-weight: 400;">Afterwards, there was a relaxed coffee break where small groups formed to exchange ideas on various topics.</p>
<p style="font-weight: 400;">Another important question for us was: &quot;What do we want as a group?&quot;„<br />
Everyone was able to record their wishes, ideas, and suggestions in writing. Lively discussions ensued, covering topics such as how often our meetings should take place, what joint activities would be possible, and what topics might be interesting for inviting speakers.</p>
<p style="font-weight: 400;">And of course, this too was essential; simply being human – laughing, talking, listening and feeling understood.<br />
To finish off the evening, we all went to a beer garden together. With good weather, delicious food, good conversation, and lots of laughter, we enjoyed a relaxing end to the day.</p>
<p><img decoding="async" class="alignnone size-medium wp-image-7403" src="https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_A-300x180.jpeg" alt="" width="300" height="180" srcset="https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_A-300x180.jpeg 300w, https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_A-1024x614.jpeg 1024w, https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_A-768x461.jpeg 768w, https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_A-18x12.jpeg 18w, https://alpha1-deutschland.org/wp-content/uploads/RNO_01Treffen_A.jpeg 1199w" sizes="(max-width: 300px) 100vw, 300px" /></p>
<p style="font-weight: 400;">For us as group leaders, it was a great meeting with lively exchange, many suggestions, and we also laughed a lot.</p>
<p style="font-weight: 400;">Thank you all for a wonderful day!</p>
<p style="font-weight: 400;"><p>The post <a href="https://alpha1-deutschland.org/en/bericht-vom-1-treffen-der-shg-rhein-neckar-odenwald">Bericht vom 1. Treffen der SHG Rhein-Neckar-Odenwald</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Seit zehn Jahren ein zweites Leben oder: Endlich wieder frei durchatmen</title>
		<link>https://alpha1-deutschland.org/en/10-jahre-transplantation</link>
		
		<dc:creator><![CDATA[Redaktion Alpha1 Deutschland e.V.]]></dc:creator>
		<pubDate>Thu, Sep 24, 2026 3:52:18 PM +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<category><![CDATA[Alpha1-Journal]]></category>
		<category><![CDATA[Alphas für Alphas]]></category>
		<category><![CDATA[Transplantation]]></category>
		<guid ispermalink="false">https://alpha1-deutschland.org/?p=7365</guid>

					<description><![CDATA[<p>The post <a href="https://alpha1-deutschland.org/en/10-jahre-transplantation">Seit zehn Jahren ein zweites Leben oder: Endlich wieder frei durchatmen</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div id="fws_6afcbd97d5362"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row full-width-section"  style="padding-top: 0px; padding-bottom: 50px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				<div class="vc_separator wpb_content_element vc_separator_align_center vc_sep_border_width_5 vc_sep_pos_align_center wpb_content_element vc_separator-has-text"   style="width: 100%;"><span class="vc_sep_holder vc_sep_holder_l"><span class="vc_sep_line"></span></span><h4>Author</h4><span class="vc_sep_holder vc_sep_holder_r"><span class="vc_sep_line"></span></span>
</div>
<div class="wpb_text_column wpb_content_element" >
	<p style="font-weight: 400;"><strong>Uwe Deter, as appeared in <a href="https://alpha1-deutschland.org/en/alpha1-journal/">Alpha1 Journal 1/2026</a>.</strong></p>
</div>



<div class="divider-wrap" data-alignment="default"><div style="margin-top: 25px; height: 5px; margin-bottom: 25px;" data-width="100%" data-animate="" data-animation-delay="" data-color="default" class="divider-border"></div></div>
<div class="wpb_text_column wpb_content_element" >
	<p>My daily routine about ten years ago was such that, as soon as I woke up and took my first breaths, I already knew roughly what the day would bring. After slowly getting dressed and washing, I would first use my inhaler, take my medication, and eat as much breakfast as I could manage. Then the day could slowly begin with my tasks: doing laundry, tidying up, or cleaning, but always with breaks in front of the television. If I was mowing the lawn for a short time, I needed a break on the bench. That was quite tiring. At midday, I usually sat down with my NIV (non-invasive ventilation) to read or watch television and often fell asleep. Afterward, I felt quite rested and had the energy to tackle the afternoon.</p>
<p>After being placed on the transplant list (October 26, 2015), my cell phone became my constant companion. When I received the first call from Hannover Medical School (MHH) on December 1, 2015, around 1 a.m., I was quite nervous and felt like I ran to the bathroom ten times before the ambulance arrived to pick me up and take me back to Hannover. Unfortunately, the lung wasn&#039;t a match, and we drove home again around 11 a.m. This experience gave us a better understanding of the process, and I was able to relax a bit. There was a second false alarm before the third call on April 21, 2016, finally led to the transplant. At the time, my wife and I were in Bremen, where the Alpha1 information day was to take place shortly afterward. At 1 a.m., I went into the hotel lobby in my tracksuit with my cell phone and wallet—that was all I needed—and was taken back to Hannover by ambulance.</p>
</div>




			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97d66f3"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				<div class="divider-wrap" data-alignment="center"><div style="margin-top: 25px; width: 20%; height: 2px; margin-bottom: 25px;" data-width="20%" data-animate="" data-animation-delay="" data-color="accent-color" class="divider-small-border"></div></div><p style="font-size: 30px;color: #004267;line-height: 2;text-align: center" class="vc_custom_heading vc_do_custom_heading" >Without the donor organ, I might not be alive today. Therefore, my greatest respect goes to the donor and his family who made this possible.</p><div class="divider-wrap" data-alignment="center"><div style="margin-top: 25px; width: 20%; height: 2px; margin-bottom: 25px;" data-width="20%" data-animate="" data-animation-delay="" data-color="accent-color" class="divider-small-border"></div></div>
			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97d7b87"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element" >
	<p>I hardly remember anything from the approximately 1.5 weeks I spent in the intensive care and intermediate care units. But what I do know is that I wasn&#039;t in pain, there was plenty of ice to soothe my throat, and Schalke won. Initially, I had some breathing difficulties and therefore received NIV ventilation for a short time to relieve the strain on my new lung.</p>
<p>I had to learn how to make my own pills, about 20 different kinds. Then, usually in the morning, the &quot;vampire&quot; would come and take my blood – there were quite a few tubes, and if I was unlucky, I also had to have a bronchoscopy, which wasn&#039;t and still isn&#039;t for me.</p>
<p>As soon as I was allowed to get up and had passed my first walking test with a walker and physical therapist, I always went to meet my wife and walked outside a lot. During rehab, they explained a lot more and we did exercises to rebuild muscle. I recommend giving your lung (or any other transplanted organ) a name, because the organ now belongs to you like a new family member, and so I named my lung Erwin. The tablets should be taken regularly, ideally at the same time each day, to ensure the levels remain consistent. At the beginning, you have to go to the doctor every week for blood tests. This interval increases, as do the follow-up visits to the transplant center.</p>
<p>Without the donor organ, I might not be alive today. Therefore, my deepest respect goes to the donor and their family who made this possible. The decision in such a situation is certainly not easy, unless you&#039;ve arranged everything beforehand and filled out an organ donor card. I hope many people carry a card that can help save someone else&#039;s life. A little bit of luck is also involved.</p>
<p>We celebrated my very personal anniversary on April 21, 2026 with 30 good friends and family over a lovely meal and great conversations.</p>
</div>




			</div> 
		</div>
	</div> 
</div></div><p>The post <a href="https://alpha1-deutschland.org/en/10-jahre-transplantation">Seit zehn Jahren ein zweites Leben oder: Endlich wieder frei durchatmen</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Neue COPD-Leitlinie: Wichtiger Schritt für die Früherkennung von Alpha-1-Antitrypsin-Mangel</title>
		<link>https://alpha1-deutschland.org/en/neue-copd-leitlinie-frueherkennung-alpha-1</link>
		
		<dc:creator><![CDATA[Redaktion Alpha1 Deutschland e.V.]]></dc:creator>
		<pubDate>Thu, Sep 24, 2026 08:53:31 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<category><![CDATA[Corona]]></category>
		<category><![CDATA[Test]]></category>
		<guid ispermalink="false">https://alpha1-deutschland.org/?p=7348</guid>

					<description><![CDATA[<p>The post <a href="https://alpha1-deutschland.org/en/neue-copd-leitlinie-frueherkennung-alpha-1">Neue COPD-Leitlinie: Wichtiger Schritt für die Früherkennung von Alpha-1-Antitrypsin-Mangel</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div id="fws_6afcbd97dc9ec"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row full-width-section"  style="padding-top: 0px; padding-bottom: 50px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				<div class="vc_separator wpb_content_element vc_separator_align_center vc_sep_border_width_5 vc_sep_pos_align_center wpb_content_element vc_separator-has-text"   style="width: 100%;"><span class="vc_sep_holder vc_sep_holder_l"><span class="vc_sep_line"></span></span><h4>Author</h4><span class="vc_sep_holder vc_sep_holder_r"><span class="vc_sep_line"></span></span>
</div>
<div class="wpb_text_column wpb_content_element" >
	<p style="font-weight: 400;"><strong>Marion Wilkens, as appeared in <a href="https://alpha1-deutschland.org/en/alpha1-journal/">Alpha1 Journal 1/2026</a>.</strong></p>
</div>



<div class="divider-wrap" data-alignment="default"><div style="margin-top: 25px; height: 5px; margin-bottom: 25px;" data-width="100%" data-animate="" data-animation-delay="" data-color="default" class="divider-border"></div></div>
<div class="wpb_text_column wpb_content_element" >
	<p>The updated S2k guideline on COPD from the German Society for Pneumology and Respiratory Medicine (DGP) sends a strong signal: In the future, every patient with COPD should be tested for alpha-1 antitrypsin deficiency (AATD) at least once in their lifetime. What sounds like a professional recommendation is, for many sufferers, a long overdue breakthrough.</p>
<p>Alpha-1 antitrypsin is a protein produced in the liver that protects the lungs from inflammation-related damage. In the liver, a malformation can lead to clumping, which can result in liver damage. If this protective protein is missing or misfolded due to a genetic defect—a condition known as alpha-1 antitrypsin deficiency—it can lead to severe pulmonary emphysema, in addition to liver damage, even at a young age. The symptoms often resemble those of &quot;classic&quot; COPD: shortness of breath, coughing, and reduced exercise tolerance. The crucial difference, however, lies in the underlying cause—and thus the possibility of more targeted therapy and early testing of family members.</p>
</div>




			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97ddd56"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				<div class="divider-wrap" data-alignment="center"><div style="margin-top: 25px; width: 20%; height: 2px; margin-bottom: 25px;" data-width="20%" data-animate="" data-animation-delay="" data-color="accent-color" class="divider-small-border"></div></div><p style="font-size: 30px;color: #004267;line-height: 2;text-align: center" class="vc_custom_heading vc_do_custom_heading" >For these people, a simple blood test means clarity – and often also relief, finally receiving an explanation for the course of the disease.</p><div class="divider-wrap" data-alignment="center"><div style="margin-top: 25px; width: 20%; height: 2px; margin-bottom: 25px;" data-width="20%" data-animate="" data-animation-delay="" data-color="accent-color" class="divider-small-border"></div></div>
			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97deebd"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element" >
	<p>It is estimated that up to 10 percent of COPD patients may carry the genetic defect, which has not yet been detected in them. In some cases, a COPD diagnosis therefore masks a rare but treatable disease. For these individuals, a simple blood test brings clarity – and often relief at finally receiving an explanation for the course of the disease. The new guideline recommendation is therefore far more than a formal adjustment. It signals the need for greater awareness, closer examination, and personalized medicine. Because only what is identified can be treated effectively. For those affected and their families, this means hope: hope for an earlier diagnosis and for tailored therapies. Sometimes, better care begins with a single, consistently performed test.</p>
</div>




			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97dfc9f"  data-column-margin="default" data-midnight="light"  class="wpb_row vc_row-fluid vc_row has-row-bg-color  right_padding_30px left_padding_30px"  style="padding-top: 30px; padding-bottom: 30px; --row-bg-color: #004267;"><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop using-bg-color"  style="background-color: #004267; "></div></div></div><div class="row_col_wrap_12 col span_12 light left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element" >
	<h3>Curious?</h3>
<p>The Alpha-1 Centers (Respiratory League) have created a detailed video on this topic:</p>
</div>



<div class="divider-wrap" data-alignment="default"><div style="height: 30px;" class="divider"></div></div><div class="nectar-cta  border_radius_6px alignment_tablet_default alignment_phone_default display_tablet_inherit display_phone_inherit font_size_desktop_1em" data-color="accent-color" data-using-bg="true" data-style="basic" data-display="block" data-alignment="left" data-text-color="custom" style="--nectar-text-color: #ffffff; --nectar-button-color: var(--nectar-accent-color); --nectar-icon-gap: 10px; "><span style="color: #ffffff;" class="nectar-button-type"><span class="link_wrap" style="padding-top: 0.65em; padding-right: 1.5em; padding-bottom: 0.65em; padding-left: 1.5em;"><a target="_blank" class="link_text" role="button" href="https://www.youtube.com/watch?v=JshS_sAWEZ4"><span class="text">Watch the video</span></a></span></span></div>
			</div> 
		</div>
	</div> 
</div></div><p>The post <a href="https://alpha1-deutschland.org/en/neue-copd-leitlinie-frueherkennung-alpha-1">Neue COPD-Leitlinie: Wichtiger Schritt für die Früherkennung von Alpha-1-Antitrypsin-Mangel</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Höhepunkte aus der Arbeit der Alpha-1 Europe Alliance im 1. Halbjahr 2026</title>
		<link>https://alpha1-deutschland.org/en/hoehepunkte-alpha-1-europe-alliance-2026</link>
		
		<dc:creator><![CDATA[Redaktion Alpha1 Deutschland e.V.]]></dc:creator>
		<pubDate>Thu, Sep 24, 2026 08:42:09 +0000</pubDate>
				<category><![CDATA[Allgemein]]></category>
		<category><![CDATA[Alpha-1 Europe Alliance]]></category>
		<category><![CDATA[Alpha1-Journal]]></category>
		<guid ispermalink="false">https://alpha1-deutschland.org/?p=7340</guid>

					<description><![CDATA[<p>The post <a href="https://alpha1-deutschland.org/en/hoehepunkte-alpha-1-europe-alliance-2026">Höhepunkte aus der Arbeit der Alpha-1 Europe Alliance im 1. Halbjahr 2026</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></description>
										<content:encoded><![CDATA[<div id="fws_6afcbd97e59de"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row full-width-section"  style="padding-top: 0px; padding-bottom: 50px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				<div class="vc_separator wpb_content_element vc_separator_align_center vc_sep_border_width_5 vc_sep_pos_align_center wpb_content_element vc_separator-has-text"   style="width: 100%;"><span class="vc_sep_holder vc_sep_holder_l"><span class="vc_sep_line"></span></span><h4>Author</h4><span class="vc_sep_holder vc_sep_holder_r"><span class="vc_sep_line"></span></span>
</div>
<div class="wpb_text_column wpb_content_element" >
	<p style="font-weight: 400;"><strong>Heinz Stutzenberger, as appeared in <a href="https://alpha1-deutschland.org/en/alpha1-journal/">Alpha1 Journal 1/2026</a>.</strong></p>
</div>



<div class="divider-wrap" data-alignment="default"><div style="margin-top: 25px; height: 5px; margin-bottom: 25px;" data-width="100%" data-animate="" data-animation-delay="" data-color="default" class="divider-border"></div></div>
<div class="wpb_text_column wpb_content_element" >
	<p><strong>As in the last reporting period, the first half of 2026 was also characterized by diverse activities of the Alpha-1 Europe Alliance (A1EA), of which only a very few can be mentioned here in focus.</strong></p>
<p>Considerable effort was invested in preparing and conducting the second meeting with Member of the European Parliament Olivier Chastel on April 22, 2026 (see the report in the Alpha1 Journal 02/2025), which this time was organized exclusively by the A1EA. The meeting focused primarily on the inequalities within Europe regarding access to augmentation therapy for Alpha-1 patients, which are particularly evident in Belgium: only patients diagnosed before 2010 receive this therapy. This is especially difficult for Belgian patients to understand, as there is a factory in the host&#039;s constituency that produces plasma-derived medications, including Alpha-1 antitrypsin. These inequalities were further highlighted in three agenda items:</p>
</div>




			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97e6d35"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element" >
	<ul>
<li><strong>During a discussion round</strong> Bernd Dobbert from Alpha1 Germany (who has been receiving augmentation therapy for years) and Knut Skaar from Alfa-1 Norden (from Norway, where augmentation therapy is not available) were able to convincingly explain from a patient perspective what the differences in access to this therapy mean for them personally.</li>
<li><strong>Prof. Gerry McElvaney, the leading physician on the subject of AATM</strong> A highly respected expert in this field in Ireland and internationally, he impressively demonstrated, based on data from everyday healthcare practice, that a comparison of countries with and without augmentation therapy can result in a life expectancy of affected Alphas that is 6.9 years longer.</li>
<li><strong>Prof. Stephanie Everaerts, who works at the University Hospital in Leuven</strong> Caring for patients with Alpha-1 Antitrypsin Deficiency (AATD) made clear the despair that grips doctors by the knowledge that life-extending therapies exist in neighboring countries which they have to withhold from their own patients.</li>
</ul>
</div>




			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97e7b5c"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				<div class="divider-wrap" data-alignment="center"><div style="margin-top: 25px; width: 20%; height: 2px; margin-bottom: 25px;" data-width="20%" data-animate="" data-animation-delay="" data-color="accent-color" class="divider-small-border"></div></div><p style="font-size: 30px;color: #004267;line-height: 2;text-align: center" class="vc_custom_heading vc_do_custom_heading" >The<br />
Speakers emphasized the need for Europe to<br />
must become independent of plasma imports, also in order to<br />
the long-term availability of plasma-based products<br />
to ensure ...</p><div class="divider-wrap" data-alignment="center"><div style="margin-top: 25px; width: 20%; height: 2px; margin-bottom: 25px;" data-width="20%" data-animate="" data-animation-delay="" data-color="accent-color" class="divider-small-border"></div></div>
			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97e8d7c"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element" >
	<p>The event was rounded off with presentations on the specific characteristics of plasma-derived medications and the availability of plasma as a starting material, of which Europe currently still has to import approximately 401 TP3T, primarily from the USA. Presentations were given by Marilena Vrana from PPTA (the association of manufacturers of plasma-derived medications), Alexander Kandt from Takeda, and Claudia Garcia Novellon from Grifols. The speakers emphasized the necessity for Europe to become independent of plasma imports, also to ensure the long-term availability of plasma-derived products, as required by the SoHO (substances of human origin) directive.</p>
<p>While the aforementioned event took place in the political heart of Europe, the Alliance was also active at the central European health institution, the European Medicines Agency (EMA). Its primary task is the approval of new medicines for all European countries. Crucial to this process is the establishment of the general framework for clinical trials, as well as the detailed specifications for conducting the trials for individual medicines. Given the large number of novel medicines under development for the AATM (Advanced Medicines Approval), it is therefore not surprising that the Alliance is striving for the greatest possible influence on behalf of patient organizations. For this reason, it has applied for registration as an &quot;eligible organization&quot; with the EMA. A prerequisite for this is the applicant&#039;s complete transparency regarding its sources of income, demonstrated through registration in the European Transparency Register.</p>
<p>This important milestone was reached in mid-March 2026. Following the submission and publication of additional management documents, only the publication of the 2025 financial data remains to complete the application process at the time of publication (Editor&#039;s note: Congratulations, as the Alliance has now been accepted as a qualified organization by the EMA).</p>
</div>




			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97e9b75"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 50px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
	<div class="wpb_gallery wpb_content_element clearfix">
		<div class="wpb_wrapper"><div class="wpb_gallery_slidesflickity_static_height_style" data-onclick="link_no" data-interval="5"><style>.wpb_gallery_slidesflickity_static_height_style .nectar-flickity.instace-6afcbd97eadf4:not(.masonry) .flickity-slider .cell img {
      height: 500px;
    }
    @media only screen and (max-width: 1300px) {
      .wpb_gallery_slidesflickity_static_height_style .nectar-flickity.instace-6afcbd97eadf4:not(.masonry) .flickity-slider .cell img {
        height: 400px;
      }
    }
    @media only screen and (max-width: 1000px) {
      .wpb_gallery_slidesflickity_static_height_style .nectar-flickity.instace-6afcbd97eadf4:not(.masonry) .flickity-slider .cell img {
        height: 350px;
      }
    }
    @media only screen and (max-width: 690px) {
      .wpb_gallery_slidesflickity_static_height_style .nectar-flickity.instace-6afcbd97eadf4:not(.masonry) .flickity-slider .cell img {
        height: 300px;
      }
    }</style><div class="nectar-flickity not-initialized instace-6afcbd97eadf4" role="region" aria-roledescription="carousel" aria-label="Image gallery"  data-touch-icon-color="default" data-drag-scale="" data-overflow="hidden" data-wrap="wrap" data-spacing="default" data-shadow="none" data-autoplay="" data-autoplay-dur="" data-free-scroll="" data-controls="pagination"><div class="flickity-viewport"> <div class="flickity-slider"><div class="cell" data-lazy="false"><img decoding="async" width="1024" height="576" src="https://alpha1-deutschland.org/wp-content/uploads/wissenschaftlicher-beirat-alpha-1-europe.jpg" class="skip-lazy nectar-lazy attachment-large" alt="Der Wissenschaftliche Beirat von Alpha-1 Europe Alliance." title="" srcset="https://alpha1-deutschland.org/wp-content/uploads/wissenschaftlicher-beirat-alpha-1-europe.jpg 1024w, https://alpha1-deutschland.org/wp-content/uploads/wissenschaftlicher-beirat-alpha-1-europe-300x169.jpg 300w, https://alpha1-deutschland.org/wp-content/uploads/wissenschaftlicher-beirat-alpha-1-europe-768x432.jpg 768w, https://alpha1-deutschland.org/wp-content/uploads/wissenschaftlicher-beirat-alpha-1-europe-18x10.jpg 18w" sizes="(max-width: 1024px) 100vw, 1024px" /><div class="item-meta"><h4 class="title"></h4><p>Image 2</p></div></div><div class="cell" data-lazy="false"><img decoding="async" width="1024" height="576" src="https://alpha1-deutschland.org/wp-content/uploads/auftaktmeeting-scientific-advisory-board.jpg" class="skip-lazy nectar-lazy attachment-large" alt="Ausschnitt aus dem Auftaktmeeting des Scientific Advisory Board von Alpha-1 Europe Alliance." title="" srcset="https://alpha1-deutschland.org/wp-content/uploads/auftaktmeeting-scientific-advisory-board.jpg 1024w, https://alpha1-deutschland.org/wp-content/uploads/auftaktmeeting-scientific-advisory-board-300x169.jpg 300w, https://alpha1-deutschland.org/wp-content/uploads/auftaktmeeting-scientific-advisory-board-768x432.jpg 768w, https://alpha1-deutschland.org/wp-content/uploads/auftaktmeeting-scientific-advisory-board-18x10.jpg 18w" sizes="(max-width: 1024px) 100vw, 1024px" /><div class="item-meta"><h4 class="title"></h4><p>Image 3</p></div></div><div class="cell" data-lazy="false"><img decoding="async" width="1024" height="576" src="https://alpha1-deutschland.org/wp-content/uploads/vorstand-alpha-1-europe-alliance-1.jpg" class="skip-lazy nectar-lazy attachment-large" alt="Aktuelle Vorstandsmitglieder von Alpha-1 Europe Alliance" title="" srcset="https://alpha1-deutschland.org/wp-content/uploads/vorstand-alpha-1-europe-alliance-1.jpg 1024w, https://alpha1-deutschland.org/wp-content/uploads/vorstand-alpha-1-europe-alliance-1-300x169.jpg 300w, https://alpha1-deutschland.org/wp-content/uploads/vorstand-alpha-1-europe-alliance-1-768x432.jpg 768w, https://alpha1-deutschland.org/wp-content/uploads/vorstand-alpha-1-europe-alliance-1-18x10.jpg 18w" sizes="(max-width: 1024px) 100vw, 1024px" /><div class="item-meta"><h4 class="title"></h4><p>Image 4</p></div></div></div></div></div></div>
		</div> 
	</div> 
			</div> 
		</div>
	</div> 
</div></div>
		<div id="fws_6afcbd97ecf6d"  data-column-margin="default" data-midnight="dark"  class="wpb_row vc_row-fluid vc_row"  style="padding-top: 0px; padding-bottom: 0px; "><div class="row-bg-wrap" data-bg-animation="none" data-bg-animation-delay="" data-bg-overlay="false"><div class="inner-wrap row-bg-layer" ><div class="row-bg viewport-desktop"  style=""></div></div></div><div class="row_col_wrap_12 col span_12 dark left">
	<div  class="vc_col-sm-12 wpb_column column_container vc_column_container col no-extra-padding inherit_tablet inherit_phone flex_gap_desktop_10px"  data-padding-pos="all" data-has-bg-color="false" data-bg-color="" data-bg-opacity="1" data-animation="" data-delay="0" >
		<div class="vc_column-inner" >
			<div class="wpb_wrapper">
				
<div class="wpb_text_column wpb_content_element" >
	<p>Even before being recognized as a &quot;qualified organization,&quot; there was already a positive collaboration between the EMA and A1EA: In April 2026, the Alliance was asked to nominate a patient who could contribute their perspective as an affected individual to the development of a new drug for AATD as part of a scientific consultation. Since this person must not have had any prior contact with other pharmaceutical companies, board members of the Alliance or national associations were not eligible. Through inquiries with the national associations, a German patient was eventually found who was suitable for this task and agreed to dedicate the necessary time. As the rest of the process is subject to strict confidentiality rules, further details cannot be disclosed.</p>
<p>There were also several noteworthy events within the A1EA organization. In April 2026, a scientific advisory board was appointed to advise the alliance on medical and research-related matters. The composition of the advisory board is shown in Figure 2; Germany is prominently represented on this board with three specialists well-known to us (Prof. Sabina Janciauskiene, Prof. Pavel Strnad, and Dr. David Katzer). Figure 3 is a photograph from the virtual launch event for this board.</p>
<p>Finally, it should be mentioned that the A1EA board members decided to step down six months earlier than stipulated in the bylaws in order to synchronize future board elections with the annual general meetings. The election took place on April 18, 2026, in Warsaw, and all board members were unanimously re-elected, with a minor change in the position of secretary. The current composition of the board is shown in Figure 4.</p>
</div>




			</div> 
		</div>
	</div> 
</div></div><p>The post <a href="https://alpha1-deutschland.org/en/hoehepunkte-alpha-1-europe-alliance-2026">Höhepunkte aus der Arbeit der Alpha-1 Europe Alliance im 1. Halbjahr 2026</a> appeared first on <a href="https://alpha1-deutschland.org/en">Ihr Online Portal für Mitglieder und Interessierte</a>.</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>